Physician profile
Michael J Stokes
NPI 1720007305
$1,682.23
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $169 · 2021: $91.44 · 2022: $555 · 2023: $398 · 2024: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $206.89 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $203.50 | 2019-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $187.29 | 2019-2024 | Watchman Flx, Watchman Access System, Watchman |
| Pfizer INC. | $181.59 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $158.30 | 2020-2024 | |
| Medtronic, INC. | $126.27 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.67 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $77.19 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $65.52 | 2022 | |
| Philips North America LLC | $63.69 | 2023 | |
| Cardiovascular Systems INC. | $53.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.45 | 2021-2022 | |
| Chiesi USA, INC. | $45.74 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $39.01 | 2021-2023 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $36.10 | 2024 | Arcalyst |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $25.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.34 | 2019-2022 | |
| Abbott Laboratories | $22.28 | 2023 | Ensite |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.78 | 2019 | |
| Cvrx, INC. | $6.11 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.